Editorial: Rising stars in hematology: 2022
- PMID: 38076238
- PMCID: PMC10703462
- DOI: 10.3389/fmed.2023.1334125
Editorial: Rising stars in hematology: 2022
Keywords: #CollectionSeries; future; hematology; review; rising stars.
Conflict of interest statement
EG has received honoraria from Alexion, Gilead, Sanofi, Sobi, and Omeros Pharmaceuticals. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Comment on
- Editorial on the Research Topic Rising stars in hematology: 2022
References
Publication types
LinkOut - more resources
Full Text Sources